NIM SUPPLEMENT AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board: TM
Tore Midtvedt1934
Years since formation: 5 years; since May 29, 2019
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 100,000; 1 share class
Total number of shareholders: 5; 2 companies, 3 persons

Financials

Total operating income 2023: 151,826; NOK
Annual total result 2023: 52,823; NOK
Total equity 2023: 139,754; NOK

Last update: Aug 29, 2024

Management

Board

Name	Role	Shares
TM Tore Midtvedt 1934	Contact Person, Chairman	45 % directly
TB Thomas Berthold Grünfeld 1964 Resigned	Board Member	16 % indirectly

Others

Name	Role	Shares
G GERHARD & SØNN AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
TM Tore Midtvedt 1934	Contact Person, Chairman	45 % directly
TB Thomas Berthold Grünfeld 1964	Board Member	16 % indirectly
JS Jacob Stolt-Nielsen 1963	-	11 % indirectly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
TM Tore Midtvedt 1934	Ordinary shares	45,000	45 %
NE Norin Elisabeth	Ordinary shares	20,000	20 %
G GRYNT HOLDING AS	Ordinary shares	16,000	16 %
S STOLT-NIELSEN HOLDING AS	Ordinary shares	11,000	11 %
MP Medi Ab Pea	Ordinary shares	8,000	8 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	151,826	96,000	33,000
Annual Total Result	52,823	78,874	-48,004
Total assets	160,150	97,323	44,200
Total liabilities	20,396	10,392	36,142
Total equity	139,754	86,931	8,057

P&L

Year	2023	2022	2021
Total operating income	151,826	96,000	33,000
Total operating costs	87,044	17,126	81,380
Operating result	64,782	78,874	-48,380
Financial income/costs	-747	0	375
Profit before tax	64,036	78,874	-48,004
Total tax & extraordinary income/cost	11,213	0	0
Annual Total Result	52,823	78,874	-48,004

Balance overview

Year	2023	2022	2021
Total fixed assets	0	0	0
Total current assets	160,150	97,323	44,200
Total assets	160,150	97,323	44,200
Short term debt	20,396	10,392	36,142
Long term debt	0	0	0
Total liabilities	20,396	10,392	36,142
Contributed capital	94,430	94,430	94,430
Retained earnings	45,324	-7,499	-86,373
Total equity	139,754	86,931	8,057
Total equity and liabilities	160,150	97,323	44,200

NIM SUPPLEMENT AS922 431 604